US Stock MarketDetailed Quotes

ABEO Abeona Therapeutics

Watchlist
  • 7.5700
  • +0.0400+0.53%
Close Apr 19 16:00 ET
207.08MMarket Cap-2992P/E (TTM)

Abeona Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
147.52%3.5M
0
0
250.00%3.5M
0
-52.87%1.41M
-97.73%68K
0
1M
346K
Operating revenue
147.52%3.5M
--0
--0
250.00%3.5M
--0
-52.87%1.41M
-97.73%68K
--0
--1M
--346K
Cost of revenue
256.67%1.61M
0
30K
350.00%1.58M
450K
100K
0
350K
Gross profit
96.58%1.9M
0
-30K
196.15%1.93M
-67.87%964K
-101.07%-32K
0
650K
Operating expense
8.38%50.1M
10.50%13.21M
20.51%11.3M
33.86%13.54M
-18.49%12.04M
-23.44%46.22M
-30.44%11.95M
-36.93%9.38M
-26.23%10.12M
1.18%14.77M
Selling and administrative expenses
10.13%19M
2.60%5.83M
6.84%4.16M
45.12%5.02M
-5.37%4M
-20.27%17.26M
29.64%5.68M
-33.12%3.89M
-33.23%3.46M
-32.74%4.22M
-General and administrative expense
10.13%19M
2.60%5.83M
6.84%4.16M
45.12%5.02M
-5.37%4M
-20.27%17.26M
29.64%5.68M
-33.12%3.89M
-33.23%3.46M
-32.74%4.22M
Research and development costs
7.34%31.09M
17.65%7.38M
30.20%7.15M
28.01%8.52M
-23.75%8.04M
-25.21%28.97M
-51.01%6.27M
-39.38%5.49M
-21.97%6.66M
26.79%10.55M
Operating profit
-6.50%-48.2M
-10.20%-13.21M
-20.83%-11.33M
-22.72%-11.62M
16.54%-12.04M
21.11%-45.26M
15.51%-11.99M
36.93%-9.38M
30.97%-9.47M
1.19%-14.42M
Net non-operating interest income expense
657.05%1.7M
322.67%634K
674.12%488K
285.80%314K
235.57%263K
91.57%-305K
412.50%150K
87.43%-85K
88.67%-169K
86.19%-194K
Non-operating interest income
391.18%2.12M
126.52%743K
723.61%593K
1,245.16%417K
5,100.00%364K
977.50%431K
6,460.00%328K
928.57%72K
287.50%31K
-53.33%7K
Non-operating interest expense
-43.21%418K
-38.76%109K
-33.12%105K
-48.50%103K
-49.75%101K
-79.87%736K
235.85%178K
-77.01%157K
-86.67%200K
-85.85%201K
Other net income (expense)
-231.04%-7.69M
-185.17%-4.02M
-132.66%-990K
-196.55%-5.35M
135.92%2.67M
124.49%5.87M
114.53%4.72M
-64.36%3.03M
5.54M
-7.43M
Gain on sale of security
-202.74%-11.7M
-178.51%-4.23M
-136.10%-1.1M
-305.55%-8.63M
280.77%2.27M
--11.38M
--5.39M
--3.05M
--4.2M
---1.25M
Special income (charges)
118.82%1.07M
--0
--0
-27.05%1.07M
--0
76.39%-5.66M
97.07%-950K
--0
--1.46M
---6.17M
-Less:Impairment of capital assets
--0
--0
--0
--0
--0
-90.31%3.15M
--0
--0
---1.46M
--6.17M
-Gain on sale of property,plant,equipment
142.41%1.07M
--0
--0
--1.07M
----
---2.51M
---950K
--0
--0
----
Other non- operating income (expenses)
1,987.23%2.94M
-22.74%214K
684.21%111K
1,977.12%2.22M
6,816.67%403K
840.00%141K
1,529.41%277K
-733.33%-19K
---118K
---6K
Income before tax
-36.51%-54.19M
-132.99%-16.59M
-83.96%-11.84M
-306.49%-16.65M
58.69%-9.11M
53.26%-39.7M
84.75%-7.12M
8.66%-6.43M
73.06%-4.1M
-37.76%-22.04M
Income tax
Net income
-36.51%-54.19M
-132.99%-16.59M
-83.96%-11.84M
-306.49%-16.65M
58.69%-9.11M
53.26%-39.7M
84.75%-7.12M
8.66%-6.43M
73.06%-4.1M
-37.76%-22.04M
Net income continuous Operations
-36.51%-54.19M
-132.99%-16.59M
-83.96%-11.84M
-306.49%-16.65M
58.69%-9.11M
53.26%-39.7M
84.75%-7.12M
8.66%-6.43M
73.06%-4.1M
-37.76%-22.04M
Minority interest income
Net income attributable to the parent company
-36.51%-54.19M
-132.99%-16.59M
-83.96%-11.84M
-306.49%-16.65M
58.69%-9.11M
53.26%-39.7M
84.75%-7.12M
8.66%-6.43M
73.06%-4.1M
-37.76%-22.04M
Preferred stock dividends
3.78M
0
3.78M
Other preferred stock dividends
Net income attributable to common stockholders
-24.63%-54.19M
-132.99%-16.59M
-83.96%-11.84M
-111.37%-16.65M
58.69%-9.11M
48.81%-43.48M
84.75%-7.12M
8.66%-6.43M
48.19%-7.88M
-37.76%-22.04M
Basic earnings per share
54.25%-2.53
-59.26%-0.64
52.00%-0.48
32.35%-0.92
85.79%-0.54
74.36%-5.53
96.43%-0.4019
44.44%-1
65.39%-1.36
10.59%-3.8
Diluted earnings per share
54.25%-2.53
-59.26%-0.64
52.00%-0.48
32.35%-0.92
85.79%-0.54
74.36%-5.53
96.43%-0.4019
44.44%-1
65.39%-1.36
10.59%-3.8
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 147.52%3.5M00250.00%3.5M0-52.87%1.41M-97.73%68K01M346K
Operating revenue 147.52%3.5M--0--0250.00%3.5M--0-52.87%1.41M-97.73%68K--0--1M--346K
Cost of revenue 256.67%1.61M030K350.00%1.58M450K100K0350K
Gross profit 96.58%1.9M0-30K196.15%1.93M-67.87%964K-101.07%-32K0650K
Operating expense 8.38%50.1M10.50%13.21M20.51%11.3M33.86%13.54M-18.49%12.04M-23.44%46.22M-30.44%11.95M-36.93%9.38M-26.23%10.12M1.18%14.77M
Selling and administrative expenses 10.13%19M2.60%5.83M6.84%4.16M45.12%5.02M-5.37%4M-20.27%17.26M29.64%5.68M-33.12%3.89M-33.23%3.46M-32.74%4.22M
-General and administrative expense 10.13%19M2.60%5.83M6.84%4.16M45.12%5.02M-5.37%4M-20.27%17.26M29.64%5.68M-33.12%3.89M-33.23%3.46M-32.74%4.22M
Research and development costs 7.34%31.09M17.65%7.38M30.20%7.15M28.01%8.52M-23.75%8.04M-25.21%28.97M-51.01%6.27M-39.38%5.49M-21.97%6.66M26.79%10.55M
Operating profit -6.50%-48.2M-10.20%-13.21M-20.83%-11.33M-22.72%-11.62M16.54%-12.04M21.11%-45.26M15.51%-11.99M36.93%-9.38M30.97%-9.47M1.19%-14.42M
Net non-operating interest income expense 657.05%1.7M322.67%634K674.12%488K285.80%314K235.57%263K91.57%-305K412.50%150K87.43%-85K88.67%-169K86.19%-194K
Non-operating interest income 391.18%2.12M126.52%743K723.61%593K1,245.16%417K5,100.00%364K977.50%431K6,460.00%328K928.57%72K287.50%31K-53.33%7K
Non-operating interest expense -43.21%418K-38.76%109K-33.12%105K-48.50%103K-49.75%101K-79.87%736K235.85%178K-77.01%157K-86.67%200K-85.85%201K
Other net income (expense) -231.04%-7.69M-185.17%-4.02M-132.66%-990K-196.55%-5.35M135.92%2.67M124.49%5.87M114.53%4.72M-64.36%3.03M5.54M-7.43M
Gain on sale of security -202.74%-11.7M-178.51%-4.23M-136.10%-1.1M-305.55%-8.63M280.77%2.27M--11.38M--5.39M--3.05M--4.2M---1.25M
Special income (charges) 118.82%1.07M--0--0-27.05%1.07M--076.39%-5.66M97.07%-950K--0--1.46M---6.17M
-Less:Impairment of capital assets --0--0--0--0--0-90.31%3.15M--0--0---1.46M--6.17M
-Gain on sale of property,plant,equipment 142.41%1.07M--0--0--1.07M-------2.51M---950K--0--0----
Other non- operating income (expenses) 1,987.23%2.94M-22.74%214K684.21%111K1,977.12%2.22M6,816.67%403K840.00%141K1,529.41%277K-733.33%-19K---118K---6K
Income before tax -36.51%-54.19M-132.99%-16.59M-83.96%-11.84M-306.49%-16.65M58.69%-9.11M53.26%-39.7M84.75%-7.12M8.66%-6.43M73.06%-4.1M-37.76%-22.04M
Income tax
Net income -36.51%-54.19M-132.99%-16.59M-83.96%-11.84M-306.49%-16.65M58.69%-9.11M53.26%-39.7M84.75%-7.12M8.66%-6.43M73.06%-4.1M-37.76%-22.04M
Net income continuous Operations -36.51%-54.19M-132.99%-16.59M-83.96%-11.84M-306.49%-16.65M58.69%-9.11M53.26%-39.7M84.75%-7.12M8.66%-6.43M73.06%-4.1M-37.76%-22.04M
Minority interest income
Net income attributable to the parent company -36.51%-54.19M-132.99%-16.59M-83.96%-11.84M-306.49%-16.65M58.69%-9.11M53.26%-39.7M84.75%-7.12M8.66%-6.43M73.06%-4.1M-37.76%-22.04M
Preferred stock dividends 3.78M03.78M
Other preferred stock dividends
Net income attributable to common stockholders -24.63%-54.19M-132.99%-16.59M-83.96%-11.84M-111.37%-16.65M58.69%-9.11M48.81%-43.48M84.75%-7.12M8.66%-6.43M48.19%-7.88M-37.76%-22.04M
Basic earnings per share 54.25%-2.53-59.26%-0.6452.00%-0.4832.35%-0.9285.79%-0.5474.36%-5.5396.43%-0.401944.44%-165.39%-1.3610.59%-3.8
Diluted earnings per share 54.25%-2.53-59.26%-0.6452.00%-0.4832.35%-0.9285.79%-0.5474.36%-5.5396.43%-0.401944.44%-165.39%-1.3610.59%-3.8
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg